Calithera Biosciences Inc (CALA)

Calithera Biosciences Inc (CALA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $487; returns 1 day +200.0%.

Calithera Biosciences, Inc. was a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule drugs for cancer treatment, specifically targeting tumor metabolism and tumor immunology. The company's primary strategy was to develop therapies for biomarker-specific patient populations.

Groups CALA belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Oncology
• Cancer Therapeutics
• Drug Discovery
• Biopharmaceutical
• Precision Medicine
• Life Sciences
• Clinical Stage
• R&D

CALA financial model: income statement, cash flow and balance sheet